S. Maita

发表

Antitumor effect of sunitinib against skeletal metastatic renal cell carcinoma through inhibition of osteoclast function

S. Kimura, T. Habuchi, N. Tsuchiya, 2012, International journal of cancer.

Bone mineral density in Japanese prostate cancer patients under androgen-deprivation therapy.

T. Habuchi, N. Tsuchiya, S. Satoh, 2008, Endocrine-related cancer.

Relationship between bone mineral density and androgen-deprivation therapy in Japanese prostate cancer patients.

T. Habuchi, N. Tsuchiya, Shinya Yamamoto, 2010, Urology.

Real-world outcomes and risk stratification in patients with metastatic castration-sensitive prostate cancer treated with upfront abiraterone acetate and docetaxel

T. Habuchi, S. Egawa, C. Ohyama, 2022, International Journal of Clinical Oncology.

Real-world survival outcomes of adding docetaxel or abiraterone in patients with high-volume metastatic castration-sensitive prostate cancer: historically controlled, propensity score matched comparison with androgen deprivation therapy

T. Habuchi, S. Egawa, C. Ohyama, 2022, World Journal of Urology.

Short-term outcomes of risk-adapted upfront docetaxel administration in patients with metastatic hormone-sensitive prostate cancer: a multicenter prospective study in Japan

T. Habuchi, C. Ohyama, N. Honma, 2021, Medical Oncology.

Organ-specific and tumor-size-dependent responses to sunitinib in clear cell renal cell carcinoma

T. Habuchi, N. Tsuchiya, S. Satoh, 2014, BMC Urology.

Inhibition of the RANK/RANKL signaling with osteoprotegerin prevents castration-induced acceleration of bone metastasis in castration-insensitive prostate cancer.

T. Habuchi, N. Tsuchiya, S. Satoh, 2017, Cancer letters.

Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility

T. Habuchi, N. Tsuchiya, S. Satoh, 2011, International journal of cancer.

Short-term clinicopathological outcome of neoadjuvant chemohormonal therapy comprising complete androgen blockade, followed by treatment with docetaxel and estramustine phosphate before radical prostatectomy in Japanese patients with high-risk localized prostate cancer

T. Habuchi, N. Tsuchiya, S. Satoh, 2012, World Journal of Surgical Oncology.

Intravesical administration of γδ T cells successfully prevents the growth of bladder cancer in the murine model

S. Kimura, T. Habuchi, N. Tsuchiya, 2009, Cancer Immunology, Immunotherapy.

Comparison of the clinical outcome and systemic inflammatory marker levels between retroperitoneal and transperitoneal laparoscopic donor nephrectomy.

T. Habuchi, N. Tsuchiya, S. Satoh, 2012, Journal of endourology.

What is the most preferred wound site for laparoscopic donor nephrectomy?: a questionnaire assessment.

T. Habuchi, N. Tsuchiya, S. Satoh, 2011, Journal of laparoendoscopic & advanced surgical techniques. Part A.

Hyperuricemia at 1 Year After Renal Transplantation, Its Prevalence, Associated Factors, and Graft Survival

T. Habuchi, N. Tsuchiya, M. Miura, 2012, Transplantation.

Laparoendoscopic single-site plus one trocar donor nephrectomy using the GelPort: initial clinical experience.

T. Habuchi, N. Tsuchiya, S. Satoh, 2013, Urology.

Comparison of surgical stress in patients undergoing open versus laparoscopic radical prostatectomy by measuring perioperative serum cytokine levels.

T. Habuchi, N. Tsuchiya, S. Satoh, 2013, Journal of laparoendoscopic & advanced surgical techniques. Part A.

Combination therapy consisting of gemcitabine, carboplatin, and docetaxel as an active treatment for advanced urothelial carcinoma

T. Habuchi, N. Tsuchiya, S. Satoh, 2011, International Journal of Clinical Oncology.

Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancer

Shigeru Satoh, Takeshi Yuasa, Takashi Obara, 2012, International Journal of Clinical Oncology.

A hemodialysis patient with dialysis-related amyloidosis that mainly affected the digestive tract and encapsulating peritoneal sclerosis at autopsy: a case study

K. Ishida, H. Oshio, S. Maita, 2020, Nihon Toseki Igakkai Zasshi.

Bone mineral density in Japanese prostate cancer patients under androgen-deprivation therapy.

T. Habuchi, N. Tsuchiya, S. Satoh, 2008, Endocrine-related cancer.

Comparison of outcomes in kidney transplantations involving blood-related and non-blood-related living donors: a multicenter retrospective study by the Michinoku renal transplant network

T. Habuchi, N. Tsuchiya, C. Ohyama, 2024, Renal Replacement Therapy.

The novel tumor‐suppressor Mel‐18 in prostate cancer: Its functional polymorphism, expression and clinical significance

T. Habuchi, O. Ogawa, N. Tsuchiya, 2009, International journal of cancer.